Evaluating the association between walking speed and reduced cardio-cerebrovascular events in hemodialysis patients: A 7-year cohort study

被引:0
|
作者
Abe Y. [1 ]
Matsunaga A. [1 ]
Matsuzawa R. [2 ]
Yoneki K. [1 ,3 ]
Harada M. [1 ]
Watanabe T. [1 ]
Kutsuna T. [4 ]
Kimura M. [5 ]
Shigeta K. [1 ]
Takeuchi Y. [6 ]
Yoshida A. [3 ]
机构
[1] Department of Rehabilitation Sciences, Kitasato University, Graduate School of Medical Sciences, 1-15-1 Kitasato, Sagamihara, Kanagawa
[2] Department of Rehabilitation, Kitasato University Hospital, Sagamihara, Kanagawa
[3] Sagami Junkanki Clinic, Sagamihara, Kanagawa
[4] Department of Rehabilitation, Kitasato University East Hospital, Sagamihara, Kanagawa
[5] School of Allied Health Sciences, Kitasato University, Sagamihara, Kanagawa
[6] School of Medicine, Kitasato University, Sagamihara, Kanagawa
基金
日本学术振兴会;
关键词
Cardio-cerebrovascular event; Disease management; Hemodialysis patient; Walking ability; Walking speed;
D O I
10.1186/s41100-016-0063-x
中图分类号
学科分类号
摘要
Background: Deterioration in walking ability characterized by slow walking speed is associated with an increased risk of mortality in patients on hemodialysis (HD), but few studies have examined the potential for walking speed to reduce the incidence of clinical events. In this study, we assessed a range of maximum walking speeds (MWS) with regard to their capacity to reduce cardio-cerebrovascular events in HD patients. Methods: In total, 188 Japanese outpatients (90 men, 98 women; mean age, 65 years) undergoing maintenance HD three times a week were monitored for 7 years. We measured clinical characteristics and MWS at baseline and followed these patients to track any cardio-cerebrovascular events. Patients were divided into quartiles (Q1 = lowest, Q4 = highest) based on MWS for each sex. Cox proportional hazards regression and Kaplan-Meier estimates were used to assess the contribution of MWS to cardio-cerebrovascular events. Results: During the follow-up period, cardio-cerebrovascular events occurred in 42 patients. After adjusting for potential confounders, the hazard ratio for events per 10 m/min increase in MWS was 0.77 (95 % confidence interval: 0.65-0.92; P = 0.004). Seven-year cumulative incidence rates were 36, 32, 13, and 9 % for Q1 through Q4, respectively, and a significant difference across MWS quartiles was observed (P < 0.001). While the incidence rates did not significantly differ between Q1 and Q2 or between Q3 and Q4, Kaplan-Meier curves clearly differed between Q2 and Q3. Conclusions: Our findings suggest that more than the MWS level of Q3 (≥89 m/min in men and ≥85 m/min in women) may serve as important MWS values for disease management in ambulatory HD patients. © 2016 The Author(s).
引用
收藏
相关论文
共 50 条
  • [21] Association between serum albumin levels and disease severity in adult patients with dengue: A 7-year retrospective cohort study in mainland China
    Wang, Changtai
    Yang, Huiqin
    Xu, Jielan
    Wang, Jian
    Zhao, Lingzhai
    Hong, Wenxin
    Zhang, Fuchun
    [J]. ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2023, 16 (05) : 204 - 212
  • [22] Implications of Albumin Leakage for Survival in Maintenance Hemodialysis Patients: A 7-year Observational Study
    Nagai, Kojiro
    Tsuchida, Kenji
    Ishihara, Noriyuki
    Minagawa, Naoto
    Ichien, Go
    Yamada, Satoshi
    Hirose, Daisuke
    Michiwaki, Hiroyuki
    Kanayama, Hiro-omi
    Doi, Toshio
    Minakuchi, Jun
    [J]. THERAPEUTIC APHERESIS AND DIALYSIS, 2017, 21 (04) : 378 - 386
  • [23] Association between cardio-cerebrovascular disease and systemic antipsoriatic therapy in psoriasis patients using population-based data: A nested case-control study
    Kim, Bo Ri
    Lee, Kun Hee
    Kim, Jinseob
    Kim, Jee Woo
    Paik, Kyungho
    Myung, Woojae
    Lee, Hyewon
    Choi, Chong Won
    Youn, Sang Woong
    [J]. JOURNAL OF DERMATOLOGY, 2023, 50 (11): : 1442 - 1449
  • [24] Periodontal disease and pneumonia mortality in haemodialysis patients: A 7-year cohort study
    Iwasaki, Masanori
    Taylor, George W.
    Awano, Shuji
    Yoshida, Akihiro
    Kataoka, Shota
    Ansai, Toshihiro
    Nakamura, Hidetoshi
    [J]. JOURNAL OF CLINICAL PERIODONTOLOGY, 2018, 45 (01) : 38 - 45
  • [25] ASSOCIATION OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS IN PITAVASTATIN TREATMENT WITH RISK OF CARDIO-CEREBROVASCULAR EVENTS IN JAPANESE PATIENTS WITH DYSLIPIDEMIA: ANALYSIS FROM THE LIVES EXTENSION
    Urashima, Mitsuyoshi
    Shimano, Hitoshi
    Yokote, Koutaro
    Saito, Yasushi
    Teramoto, Tamio
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E520 - E520
  • [26] Lipoprotein-associated phospholipase A2 predicts cardiovascular death in patients on maintenance hemodialysis: a 7-year prospective cohort study
    Lin, Lin
    Teng, Jie
    Shi, Yiqin
    Xie, Qiwen
    Shen, Bo
    Xiang, Fangfang
    Cao, Xuesen
    Ding, Xiaoqiang
    Xu, Xialian
    Zhang, Zhen
    [J]. LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [27] Lipoprotein-associated phospholipase A2 predicts cardiovascular death in patients on maintenance hemodialysis: a 7-year prospective cohort study
    Lin Lin
    Jie Teng
    Yiqin Shi
    Qiwen Xie
    Bo Shen
    Fangfang Xiang
    Xuesen Cao
    Xiaoqiang Ding
    Xialian Xu
    Zhen Zhang
    [J]. Lipids in Health and Disease, 23
  • [28] The association between dose of hemodialysis and patients mortality in a prospective cohort study
    Liu, Shu-Xin
    Wang, Zhi-Hong
    Zhang, Shuang
    Xiao, Jia
    You, Lian-Lian
    Zhang, Yu
    Dong, Cui
    Wang, Xue-Na
    Wang, Zhen-Zhen
    Wang, Sheng-Nan
    Song, Jia-Ni
    Zhao, Xiu-Nan
    Yan, Xin-Yi
    Yu, Shu-Fan
    Zhang, Yi-Nan
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [29] The association between dose of hemodialysis and patients mortality in a prospective cohort study
    Shu-Xin Liu
    Zhi-Hong Wang
    Shuang Zhang
    Jia Xiao
    Lian-Lian You
    Yu Zhang
    Cui Dong
    Xue-Na Wang
    Zhen-Zhen Wang
    Sheng-Nan Wang
    Jia-Ni Song
    Xiu-Nan Zhao
    Xin-Yi Yan
    Shu-Fan Yu
    Yi-Nan Zhang
    [J]. Scientific Reports, 12
  • [30] Significant association of anti-platelet factor 4/heparin antibody with cardiovascular disease in hemodialysis patients: a longitudinal 7-year study
    Chi-Chu Liu
    Li-Ping Chou
    Tsang-Shan Chen
    Chien-An Chen
    Yueh-Feng Tsai
    [J]. International Urology and Nephrology, 2018, 50 : 2289 - 2297